Fidji Simo welcomes ChronicleBio AI, backed by Morgan Cheatham and Jimi Hendrix
Original titleVery excited to work with @morgancheatham @jimihendrixlive on this; they were one of the first investors to bet on the importance of data...
AISummary
Fidji Simo says she is excited to work with Morgan Cheatham and Jimi Hendrix, two early investors who recognized the importance of data in AI biotech.
Morgan Cheatham's linked post says the partnership supports ChronicleBio, which is building AI models to identify biologically distinct patient subgroups within complex chronic diseases.
The team reportedly combines clinical phenotyping, molecular measurement, and AI, and its early work has surfaced disease subtypes linked to potentially relevant therapies.
Source: Fidji Simo · x.comPublished · added here